Course Objectives
Upon completion of this course, participants should be able to:
- Interpret corneal tomography, anterior segment OCT, high-resolution OCT, and in vivo confocal microscopy to diagnose corneal and ocular surface disease and guide cataract, refractive, and keratoplasty planning.
- Formulate individualized treatment plans for dry eye disease, meibomian gland dysfunction, Demodex blepharitis, neurotrophic keratopathy, cicatrizing conjunctivitis, neuropathic corneal pain, and other complex ocular surface disorders.
- Diagnose and manage common and challenging corneal infections using clinical findings, advanced imaging, and evidence-based conventional and adjunctive therapies.
- Compare advanced intraocular lens technologies—including enhanced monofocal, EDOF, light-adjustable, and accommodating lenses—and individualize lens selection and patient counseling based on corneal optics, ocular comorbidities, and visual goals.
- Plan cataract surgery in eyes with keratoconus, uveitis, autoimmune disease, neurotrophic cornea, or concomitant glaucoma, and recognize and manage postoperative complications including dysphotopsia, persistent inflammation, and endophthalmitis.
- Select appropriate surgical strategies for traumatic cataract, zonular or capsular instability, aphakia, and iris defects, including capsular tension devices, secondary IOLs, iris repair, and artificial iris implantation.
- Apply tomographic and biomechanical principles to evaluate corneal ectasia and select appropriate candidates for contemporary corneal refractive surgery, including SMILE.
- Use clinical findings, registry data, and long-term outcomes evidence to select the timing and technique for endothelial and lamellar keratoplasty and to prevent or manage complications in routine and high-risk eyes.
- Diagnose and stage limbal stem cell deficiency and determine the appropriate role and sequencing of cultivated limbal epithelial transplantation, keratoplasty, and other ocular surface therapies.
- Critically appraise emerging approaches—including corneal endothelial cell therapy, pharmacologic regeneration, AI-assisted imaging, telemedicine, remote monitoring, and wearable technology—considering their evidence, limitations, and potential clinical applications.